Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Clinical Trial
Share your love
Ocular Therapeutix Gets FDA Agreement for Wet AMD Trial
Ocular Therapeutix has obtained written FDA approval for the comprehensive design of its pivotal phase 3 clinical trial, known as the SOL trial, which evaluates Axpaxli (axitinib intravitreal implant) for treating wet age-related macular degeneration (AMD) under a Special Protocol…
FDA Greenlights Phase 1 Trial for IOPCL Magnifier
OnPoint Vision has officially received FDA approval for their investigational device exemption (IDE) application, initiating the phase 1 in the pivotal clinical trial for the AccuraSee Intraocular Pseudophakic Capsular Lens (IOPCL) Magnifier (MAG). This trial focuses on the secondary implantation…
Ocuphire and Viatris Unveil FDA Approval for Ryzumvi
Ocuphire Pharma and Viatris announced that the FDA has granted approval for Ryzumvi (phentolamine ophthalmic solution) 0.75%. This approval specifically authorizes its use in the treatment of pharmacologically-induced mydriasis, produced by adrenergic agonists (such as phenylephrine) or parasympatholytic agents (like…
Neurophth’s ADOA Candidate Drug Gets Australian Approval
Neurophth Therapeutics announced that the Australian Therapeutic Goods Administration (TGA) has granted registration and approval for its candidate drug, NFS-05, for clinical trials aimed at addressing autosomal dominant optic atrophy (ADOA). According to a company news release, ADOA is an…
What is Pneumatic Retinopexy? I OBN
Pneumatic retinopexy is an in-office procedure used to repair certain types of retinal detachments. Pneumatic retinopexy typically treats rhegmatous retinal detachments. The eye is numbed with anesthesia so there is no pain. A gas bubble is injected into the eye…
Alcon Introduces Launch Of AcrySof IQ Vivity
Development of active glasses for mitigating presbyopia has become an active area of research, facilitated by the miniaturization of focus-tunable lenses as well as the increased processing power of modern computers. Alcon the global leader in eye care dedicated to…
Marinomed Set to Launch Carragelose Eye Drops in 2024
Marinomed Biotech has announced the introduction of a new Carragelose eye drop product, known as MAM-1001-3, to their existing Carragelose OTC portfolio. The product has obtained certification under the Medical Device Directive (MDD) and is currently undergoing preparations for marketing.…
New Guidelines By The European Glaucoma Society I OBN
New theories about the causes, processes, and treatments of glaucoma are constantly being developed. The European Glaucoma Society’s mission is to advance the greatest level of health and the least amount of glaucoma-related visual impairment among glaucoma patients within an…
TearRestore’s New Dry Eye Products Are Available at Target
TearRestore has recently announced that their Thermal Mask and Eyelid Wipes will now be available for purchase both in Target stores across the United States and on Target’s online shopping platform, Target.com. According to TearRestore, their Thermal Mask and Eye…
ChatGPT Scores Nearly 50% on Ophthalmology Exam
ChatGPT, an artificial intelligence tool, was found to have a low accuracy rate, answering less than half of the questions from a commonly used study resource for physicians preparing for board certification in ophthalmology, according to a study led by…